ATXN2 and Atrophy/Degeneration affecting the brainstem: Brainstem atrophy was also observed in 22 SCA patients (66.7%) although it was rare in the SCA6 subgroup (10% vs. SCA2, 100%; SCA3, 66.7%; SCA7, 100%).